Interventional Pain Institute, LLC

Interventional Pain Institute, LLC was paid $5.00M by Medicaid between Jan 2018 and Dec 2023, across 86 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	5,727	$88K
2019	4,732	$78K
2020	33,611	$1.47M
2021	31,050	$1.40M
2022	20,159	$1.14M
2023	10,487	$816K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	29%	19,737	10,675	$1.42M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	19%	7,964	5,937	$954K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	14%	11,983	7,199	$699K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	12%	12,506	7,407	$589K
95923		3.2%	2,404	1,727	$157K
95913		2.7%	933	645	$135K
95921		1.9%	2,401	1,724	$94K
93922		1.6%	1,217	921	$81K
76800		1.3%	989	703	$64K
95886		1.2%	1,722	649	$61K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.2%	528	384	$58K
76881		1.0%	998	703	$51K

74 more codes

97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	2,528	$46K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	463	$42K
92270		<1%	888	$41K
76942		<1%	1,015	$40K
95887		<1%	926	$34K
92546		<1%	751	$32K
95926		<1%	435	$30K
92540		<1%	449	$25K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,236	$23K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,787	$22K
96132		<1%	425	$22K
95925		<1%	289	$21K
96127		<1%	2,824	$21K
72275		<1%	252	$19K
96116		<1%	479	$17K
64483		<1%	69	$15K
99406		<1%	1,026	$14K
92548		<1%	445	$14K
64493		<1%	105	$14K
92537		<1%	449	$10K
99070		<1%	801	$9K
97124		<1%	728	$9K
64494		<1%	121	$8K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	123	$8K
64495		<1%	102	$7K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,227	$7K
96138		<1%	425	$7K
64484		<1%	84	$7K
97750		<1%	435	$6K
97012		<1%	938	$6K
G9903	Patient screened for tobacco use and identified as a tobacco non-user	<1%	599	$5K
99215	Doctor's office visit, returning patient (complex)	<1%	68	$5K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	594	$4K
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	<1%	2,768	$4K
97010		<1%	1,867	$4K
G8950	Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented	<1%	840	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,093	$4K
20553		<1%	155	$3K
G8482	Influenza immunization administered or previously received	<1%	477	$3K
99443		<1%	125	$2K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	357	$2K
G8730	Pain assessment documented as positive using a standardized tool and a follow-up plan is documented	<1%	1,908	$2K
97026		<1%	219	$2K
92547		<1%	450	$1K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	168	$1K
97164		<1%	92	$1K
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	135	$1K
86328		<1%	40	$950.51
77003		<1%	16	$707.04
97537		<1%	76	$703.90
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	130	$659.98
1006F		<1%	793	$549.67
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	<1%	68	$441.50
97014		<1%	84	$413.16
97535	Self-care/home management training, each 15 minutes	<1%	68	$406.53
99484		<1%	40	$311.52
97116		<1%	17	$309.12
81001		<1%	86	$230.93
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	<1%	36	$194.58
4004F		<1%	580	$62.50
3700F		0%	1,370	$0.00
G9906	Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)	0%	296	$0.00
1036F		0%	131	$0.00
1101F		0%	53	$0.00
G9902	Patient screened for tobacco use and identified as a tobacco user	0%	365	$0.00
Q4206	Fluid flow or fluid gf, 1 cc	0%	58	$0.00
G9908	Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)	0%	45	$0.00
G8952	Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given	0%	14	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	34	$0.00
G8783	Normal blood pressure reading documented, follow-up not required	0%	147	$0.00
G8511	Screening for depression documented as positive, follow-up plan not documented, reason not given	0%	26	$0.00
96103		0%	24	$0.00
G9500	Radiation exposure indices documented in final report for procedure using fluoroscopy	0%	14	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	33	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHARMA, MANEESH (MEDICAL DIRECTOR-OWNER)